8 independently sourced, verified trend briefs about this subject.
Newsylist includes a story here only after at least four independent sources support it and its brief passes the verification check. The qualifying coverage spans 1 news category, from Jun 25, 2026 through Jul 30, 2026.
The cards below are ordered newest first. Each opens the underlying timeline, source list, coverage velocity and verification context; raw or extractive-only records are excluded.
Use of GLP-1 weight loss medications has reached a new high in the United States, sparking debate over long-term efficacy and accessibility.
Medicare now provides access to GLP-1 weight-loss drugs as utilization rates among U.S. adults reach one in eight.
Health officials and media are warning of a surge in type 2 diabetes cases among women in their 20s and those under 40.
A new study suggests obesity is preventing more than 600,000 people in the UK from entering the workforce.
New evidence suggests GLP-1 medications, including Ozempic and Wegovy, may serve as a promising treatment for binge eating disorder.
New research suggests statins and blood pressure medications are narrowing the heart risk gap between adults with obesity and those of a healthy weight.
Obesity-linked heart conditions are projected to cause approximately 170,000 deaths in England by 2035.
Recent data indicates that obesity cases are increasing most rapidly among young adults, sparking widespread health concerns.